Certain features of will be down for maintenance the evening of Friday August 18th starting at 8:00 pm CDT until Saturday August 19th at 12:01 pm CDT.   Please note that you still have telephone and email access to our local offices. We apologize for any inconvenience.

Cardiac Drugs

Worldwide cardiovascular disease (CVD) prevalence is increasing, with countries such as China projecting a 73% increase in their CVD rates by 20301 and England projecting a 15% increase by 2020.2 Nearly all cardiac drugs have a narrow therapeutic range requiring careful therapeutic drug monitoring (TDM) to minimize any adverse side effects associated with these medications and to ensure effectiveness of the drug regimen.

Sigma-Aldrich's Cerilliant brand offers a wide selection of Certified Spiking Solutions® for a variety of cardiac drugs from antiarrhythmics, anticoagulants, and antihypertensives to vasodilators and beta blockers. Cerilliant’s cardiac drug Certified Spiking Solutions® include parent drugs, stable-labeled internal standards, and metabolites for use in therapeutic drug monitoring, clinical and diagnostic testing, forensic analysis, and clinical toxicology applications.

Cerilliant’s Certified Spiking Solutions® are prepared and certified to the highest industry standards including ISO Guide 34, ISO/IEC 17025, and ISO 13485. Our comprehensive Certificate of Analysis (COA) provides all analytical data on homogeneity, accuracy of concentration as compared to a calibration curve, and uncertainty and traceability information to support regulatory requirements.


Related Links